Elevance Health Basic EPS 2010-2024 | ELV
Elevance Health annual/quarterly basic eps history and growth rate from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Elevance Health basic eps for the quarter ending September 30, 2024 was $4.38, a 20.07% decline year-over-year.
- Elevance Health basic eps for the twelve months ending September 30, 2024 was $27.64, a 9.08% increase year-over-year.
- Elevance Health annual basic eps for 2023 was $0.025B, a 3.34% increase from 2022.
- Elevance Health annual basic eps for 2022 was $0.025B, a 2.77% decline from 2021.
- Elevance Health annual basic eps for 2021 was $0.025B, a 38.56% increase from 2020.
| Elevance Health Annual Basic EPS | |
|---|---|
| 2023 | $25.38 |
| 2022 | $24.56 |
| 2021 | $25.26 |
| 2020 | $18.23 |
| 2019 | $18.81 |
| 2018 | $14.53 |
| 2017 | $14.70 |
| 2016 | $9.39 |
| 2015 | $9.73 |
| 2014 | $9.31 |
| 2013 | $8.34 |
| 2012 | $8.26 |
| 2011 | $7.35 |
| 2010 | $7.03 |
| 2009 | $9.96 |
| Elevance Health Quarterly Basic EPS | |
|---|---|
| 2024-09-30 | $4.38 |
| 2024-06-30 | $9.91 |
| 2024-03-31 | $9.65 |
| 2023-12-31 | $3.70 |
| 2023-09-30 | $5.48 |
| 2023-06-30 | $7.83 |
| 2023-03-31 | $8.37 |
| 2022-12-31 | $3.66 |
| 2022-09-30 | $6.69 |
| 2022-06-30 | $6.80 |
| 2022-03-31 | $7.41 |
| 2021-12-31 | $4.93 |
| 2021-09-30 | $6.20 |
| 2021-06-30 | $7.33 |
| 2021-03-31 | $6.80 |
| 2020-12-31 | $2.30 |
| 2020-09-30 | $0.88 |
| 2020-06-30 | $9.02 |
| 2020-03-31 | $6.03 |
| 2019-12-31 | $3.70 |
| 2019-09-30 | $4.64 |
| 2019-06-30 | $4.44 |
| 2019-03-31 | $6.03 |
| 2018-12-31 | $1.63 |
| 2018-09-30 | $3.70 |
| 2018-06-30 | $4.07 |
| 2018-03-31 | $5.13 |
| 2017-12-31 | $4.78 |
| 2017-09-30 | $2.87 |
| 2017-06-30 | $3.23 |
| 2017-03-31 | $3.82 |
| 2016-12-31 | $1.38 |
| 2016-09-30 | $2.35 |
| 2016-06-30 | $2.97 |
| 2016-03-31 | $2.69 |
| 2015-12-31 | $0.70 |
| 2015-09-30 | $2.51 |
| 2015-06-30 | $3.27 |
| 2015-03-31 | $3.25 |
| 2014-12-31 | $1.90 |
| 2014-09-30 | $2.31 |
| 2014-06-30 | $2.64 |
| 2014-03-31 | $2.46 |
| 2013-12-31 | $0.54 |
| 2013-09-30 | $2.21 |
| 2013-06-30 | $2.67 |
| 2013-03-31 | $2.92 |
| 2012-12-31 | $1.57 |
| 2012-09-30 | $2.17 |
| 2012-06-30 | $1.96 |
| 2012-03-31 | $2.56 |
| 2011-12-31 | $1.03 |
| 2011-09-30 | $1.92 |
| 2011-06-30 | $1.92 |
| 2011-03-31 | $2.48 |
| 2010-12-31 | $1.45 |
| 2010-09-30 | $1.86 |
| 2010-06-30 | $1.73 |
| 2010-03-31 | $1.99 |
| 2009-12-31 | $5.80 |
| 2009-09-30 | $1.55 |
| 2009-06-30 | $1.44 |
| 2009-03-31 | $1.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $98.015B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $48.948B | 18.05 |
| DiDi Global (DIDIY) | China | $23.622B | 0.00 |
| ICON (ICLR) | Ireland | $17.731B | 15.79 |
| Natera (NTRA) | United States | $16.587B | 0.00 |
| Viatris (VTRS) | United States | $15.469B | 4.76 |
| Avantor (AVTR) | United States | $15.375B | 23.05 |
| Revvity (RVTY) | United States | $14.905B | 25.89 |
| BioMerieux (BMXMF) | France | $13.087B | 0.00 |
| CochLear (CHEOY) | Australia | $12.590B | 0.00 |
| Solventum (SOLV) | United States | $12.509B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.276B | 31.77 |
| Charles River Laboratories (CRL) | United States | $11.014B | 21.28 |
| Doximity (DOCS) | United States | $10.815B | 64.01 |
| HealthEquity (HQY) | United States | $8.629B | 46.83 |
| Sonic Healthcare (SKHHY) | Australia | $8.542B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $7.043B | 32.79 |
| Life Times (LTH) | United States | $5.170B | 34.22 |
| Sotera Health (SHC) | United States | $4.557B | 24.38 |
| Organon (OGN) | United States | $4.131B | 4.17 |
| Surgery Partners (SGRY) | United States | $3.859B | 42.76 |
| BrightSpring Health Services (BTSG) | United States | $3.408B | 72.48 |
| PACS (PACS) | United States | $3.251B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.620B | 0.00 |
| Concentras Parent (CON) | United States | $2.500B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.337B | 0.00 |
| Premier (PINC) | United States | $2.292B | 11.44 |
| GeneDx Holdings (WGS) | United States | $2.137B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
| Teladoc Health (TDOC) | United States | $1.589B | 0.00 |
| Progyny (PGNY) | United States | $1.499B | 26.37 |
| Pediatrix Medical (MD) | United States | $1.353B | 13.24 |
| Establishment Labs Holdings (ESTA) | $1.292B | 0.00 | |
| CareDx (CDNA) | United States | $1.268B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.104B | 7.49 |
| Embecta (EMBC) | United States | $0.897B | 5.98 |
| InnovAge Holding (INNV) | United States | $0.813B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.757B | 0.00 |
| SBC Medicals (SBC) | United States | $0.706B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.469B | 0.00 |
| DocGo (DCGO) | United States | $0.409B | 15.38 |
| Enhabit (EHAB) | United States | $0.397B | 34.30 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.373B | 0.00 |
| LifeMD (LFMD) | United States | $0.252B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.225B | 0.00 |
| ModivCare (MODV) | United States | $0.221B | 12.05 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| Biodesix (BDSX) | United States | $0.199B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| MultiPlan (MPLN) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| So-Young (SY) | China | $0.089B | 21.63 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.055B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.11 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |